← Back to MIRA

MIRA Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 12/08/2026Sep 2025Filed 13/11/2025Jun 2025Filed 12/08/2026Mar 2025Filed 12/08/2026Sep 2024Filed 13/11/2025Jun 2024Filed 13/11/2025Mar 2024Filed 13/11/2025
−$1.2−$1.2−$1.1−$1.5−$1.8−$2−$1.7−$1.7
−$0.03−$0.03−$1.18−$0.09−$0.11−$0.14−$0.11−$0.15
4242191717151515

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.